SenesTech, Inc. (SNES) · Oct 15, 2026 · Earnings
Revenue milestone — Preliminary revenue ~$1.1M, up 40% sequentially and 55% year over year
SenesTech’s preliminary Q3 earnings show revenue crossing $1 million for the first time, but margins and cash flow remain unreported.
SenesTech is transitioning from a research-focused company into a revenue-driven rodent-control business, using direct e-commerce, subscriptions and a more focused B2B sales effort to build a scalable commercial model. Its recent strategy has centered on bringing Amazon management in-house, expanding direct online sales and using subscriptions to make revenue more recurring.
| Metric | Q3 2026 preliminary result | Comparison |
|---|---|---|
| Revenue | ~$1.1 million (Exhibit 99.1 — preliminary revenue) | +40% vs. Q2 2026; +55% vs. Q3 2025 |
| Revenue threshold | First quarter at or above $1 million (Exhibit 99.1 — preliminary revenue) | Second consecutive quarterly record |
The commercial transition is producing a real topline milestone. Preliminary revenue reached approximately $1.1 million, up about 40% from the prior quarter and 55% from the year-ago quarter. This is the first time SenesTech has reached the $1 million quarterly threshold and confirms that the sharp Q2 acceleration was not immediately reversed.
The result is better than the standing business assumption, but not a surprise in direction. Q2 had already established record revenue, record e-commerce sales and sharply higher subscription revenue, so continued growth was the expected path; the new information is the magnitude and the crossing of the $1 million mark. Q2 revenue was reported at $770,000, with e-commerce at $511,000 and subscription revenue at $104,000. No reliable published Q3 revenue consensus was identified for this very small-cap name, so the cleanest benchmark is SenesTech’s own recent trajectory rather than a formal analyst estimate.
The quality of growth appears to be improving, but this filing does not prove the economics yet. Management says e-commerce and subscription revenue continued to expand, while B2B traction increased. That supports the strategy’s commercial logic, especially after Q2’s strong e-commerce and subscription growth. But the release gives no finalized gross margin, operating loss, cash balance or cash burn, and the revenue remains unaudited and subject to adjustment. 〔0〕
Bottom line: This advances SenesTech’s core turnaround story: the e-commerce-led model is generating a second consecutive record and has now crossed a meaningful scale threshold. It is a genuine topline positive, but the definitive Q3 report must show whether the growth is translating into better margins and lower cash pressure.
Q3 results, week of November 9
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!